Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
CLEO Diagnostics Ltd ( (AU:COV) ) has issued an update.
CLEO Diagnostics Ltd has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement confirms the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, highlighting their commitment to transparency and accountability in management and oversight.
More about CLEO Diagnostics Ltd
Average Trading Volume: 68,152
Technical Sentiment Signal: Hold
For an in-depth examination of COV stock, go to TipRanks’ Overview page.